Robert S. Rosenson

3.8k total citations · 2 hit papers
22 papers, 2.8k citations indexed

About

Robert S. Rosenson is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robert S. Rosenson has authored 22 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robert S. Rosenson's work include Lipoproteins and Cardiovascular Health (15 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Robert S. Rosenson is often cited by papers focused on Lipoproteins and Cardiovascular Health (15 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Robert S. Rosenson collaborates with scholars based in United States, Netherlands and Canada. Robert S. Rosenson's co-authors include Vallerie V. McLaughlin, Michael D. McGoon, Michael A. Mathier, Stephen L. Archer, Robyn J. Barst, Victor F. Tapson, Harrison W. Farber, Myung H. Park, John Varga and Lewis J. Rubin and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Medicine and The American Journal of Cardiology.

In The Last Decade

Robert S. Rosenson

20 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

2009 1.8k citations Vallerie V. McLaughlin, Stephen L. Archer et al. Journal of the American College of Cardiology profile →
An assessment by the Statin Muscle Safety Task Force: 2014 update

2014 346 citations Robert S. Rosenson, Steven K. Baker et al. Journal of clinical lipidology profile →

Peers

Countries citing papers authored by Robert S. Rosenson

Since Specialization

Citations

This map shows the geographic impact of Robert S. Rosenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Rosenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Rosenson more than expected).

Fields of papers citing papers by Robert S. Rosenson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Rosenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Rosenson. The network helps show where Robert S. Rosenson may publish in the future.

Co-authorship network of co-authors of Robert S. Rosenson

This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Rosenson. A scholar is included among the top collaborators of Robert S. Rosenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Rosenson. Robert S. Rosenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HIGH LP(A) INCREASES THROMBOGENICITY PARTICULARLY IN PATIENTS WITH RS3798220-CSNP 2025 ·Journal of the American College of Cardiology ·(unknown), M. Urooj Zafar, (unknown), (unknown), Ginés Escolar, Juan J. Badimón, Robert S. Rosenson	0
2	THE IMPACT OF ADHERENCE TO LDL-C LOWERING THERAPIES ON CARDIOVASCULAR EVENTS AMONG ADULTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA AND PRIMARY HYPERLIPIDEMIA 2025 ·Journal of the American College of Cardiology ·Robert S. Rosenson, Jason Shafrin, Xiaoli Niu, (unknown), (unknown), Yousuf Ali, Sean McElligott	2
3	Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence 2018 ·Cardiovascular Research ·Liam R. Brunham, Steven K. Baker, Andrew L. Mammen, G.B. John Mancini, Robert S. Rosenson	46
4	Systematic Review of Methods Used for the Microvascular Assessment of Peripheral Arterial Disease 2018 ·Cardiovascular Drugs and Therapy ·Qinzhong Chen, Robert S. Rosenson	9
5	Persistent Safety and Efficacy of Evolocumab in Patients with Statin Intolerance: a Subset Analysis of the OSLER Open-Label Extension Studies 2018 ·Cardiovascular Drugs and Therapy ·Leslie Cho, Ricardo Dent, Erik S.G. Stroes, Evan A. Stein, David Sullivan, Andrea Ruzza, (unknown), Ransi Somaratne, Robert S. Rosenson	18
6	Trial designs for statin muscle intolerance 2017 ·Current Opinion in Lipidology ·Robert S. Rosenson	5
7	The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability 2017 ·Cardiovascular Drugs and Therapy ·Robert S. Rosenson, (unknown), Martha Bayliss, Robert J. Sanchez, Marie T. Baccara‐Dinet, (unknown), Beth A. Taylor, Irfan Khan, Garen Manvelian, Michelle K. White, Terry A. Jacobson	95
8	Primary Care Physician Perspectives on Barriers to Statin Treatment 2017 ·Cardiovascular Drugs and Therapy ·Rikki M. Tanner, Monika M. Safford, Keri L. Monda, Benjamin Taylor, Rónán O’Beirne, Melanie S. Morris, Lisandro D. Colantonio, Ricardo Dent, Paul Muntner, Robert S. Rosenson	20
9	Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study 2016 ·Cardiovascular Drugs and Therapy ·Leslie Cho, Michael Rocco, David Colquhoun, David Sullivan, Robert S. Rosenson, Ricardo Dent, Allen Xue, Robert C. Scott, Scott M. Wasserman, Erik S.G. Stroes	15
10	Identification and management of patients with statin-associated symptoms in clinical practice: A clinician survey 2015 ·Atherosclerosis ·G. Kees Hovingh, Shravanthi R. Gandra, Jan McKendrick, Ricardo Dent, (unknown), Alberico L. Catapano, Paul Oh, Robert S. Rosenson, Erik S.G. Stroes	45
11	An assessment by the Statin Muscle Safety Task Force: 2014 update breakdown → 2014 ·Journal of clinical lipidology ·Robert S. Rosenson, Steven K. Baker, Terry A. Jacobson, Stephen L. Kopecky, Beth A. Parker	346
12	ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension breakdown → 2009 ·Journal of the American College of Cardiology ·Vallerie V. McLaughlin, Stephen L. Archer, David B. Badesch, Robyn J. Barst, Harrison W. Farber, Jonathan R. Lindner, Michael A. Mathier, Michael D. McGoon, Myung H. Park, Robert S. Rosenson, Lewis J. Rubin, Victor F. Tapson, John Varga	1813
13	SPARCL: Statin therapy for stroke patients is not crystal clear 2007 ·Current Atherosclerosis Reports ·Robert S. Rosenson	0
14	An Assessment of Statin Safety by Muscle Experts 2006 ·The American Journal of Cardiology ·Paul D. Thompson, Priscilla M. Clarkson, Robert S. Rosenson	201
15	Critical appraisal of revised cholesterol guidelines for the very high-risk patient 2005 ·Expert Review of Cardiovascular Therapy ·Robert S. Rosenson, Donald M. Lloyd‐Jones	5
16	Antiatherothrombotic effects of nicotinic acid 2003 ·Atherosclerosis ·Robert S. Rosenson	60
17	Assessing Coronary Heart Disease Risk and Managing Lipids 2001 ·The Nurse Practitioner ·Lynne T. Braun, Robert S. Rosenson	2
18	2001 ·Journal of Cardiovascular Risk ·Beth A. Staffileno, Lynne T. Braun, Robert S. Rosenson	14
19	The Accumulative Effects of Physical Activity in Hypertensive Post-Menopausal Women 2001 ·European Journal of Cardiovascular Prevention & Rehabilitation ·Beth A. Staffileno, Lynne T. Braun, Robert S. Rosenson	31
20	Lovastatin-associated sleep and mood disturbances 1993 ·The American Journal of Medicine ·Robert S. Rosenson, (unknown)	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact